Limited License States for everything CannabisYou cant compare Cdn stocks at all to IAN and hence the strategic focus of Ianthus is why i bought them. Your overgeneralization to the whole industry. Sell anything CDN buy IAN. is correct.
Yesterdays post was Cannacord buy recomendation to $10. Heres one to $8
Globe says Stanley maintains iAnthus Capital at "buy"
2019-08-29 07:57 ET - In the News
The Globe and Mail reports in its Thursday, Aug. 29, edition that Beacon Securities analyst Russell Stanley cut his share target on Ianthus Capital Holdings to $8 from $12 after second quarter results fell short of expectations. The Globe's Gillian Livingston writes that Mr. Stanley reiterated Ianthus at "buy." Mr. Stanley says in a note: "Following the release of the Q2/19 results yesterday, we are reducing our F2019 and F2020 estimates. We are also introducing estimates for F2021, and rolling forward our valuation, using a 15 times EV/2021E EBITDA multiple, which is in line with the multiple we use to value other multi-state operators. We continue to believe IAN is well positioned in some of the most attractive cannabis markets in the U.S., and our forecast revisions are intended to better reflect the likely ramp up time required to monetize those opportunities. While our F2021 forecast is roughly in line with consensus, our F2020 estimates are well below current consensus, reflecting our view that the revenue ramp up may take more time than our peers currently assume. IAN is now trading at 7 times our F2021 EBITDA forecast. This represents a 16 per cent discount to the 8 times average for the broad peer group."
© 2019 Canjex Publishing Ltd. All rights